Organization

Johns Hopkins University

195 clinical trials

8 abstracts

2 posters

Clinical trial
AERO: Adjuvant EveRolimus Outcomes in Laryngotracheal Stenosis
Status: Active (not recruiting), Estimated PCD: 2025-03-01
Abstract
Clinical and analytical validation of a targeted gene expression biomarker predicting meningioma outcomes and radiotherapy responses.
Org: University of California-San Francisco, University of Chicago Medical Center, Chicago, IL, University of California San Francisco, University Clinic of Heidelberg, UCSF Department of Radiation Oncology,
Abstract
Comparative effectiveness trial of early palliative care delivered via telehealth versus in person among patients with advanced lung cancer.
Org: Massachusetts General Hospital, Harvard Medical School, Boston, MA, Johns Hopkins University, Baltimore, MD,
Abstract
Cabazitaxel with abiraterone versus abiraterone alone randomized trial for extensive disease following docetaxel: The CHAARTED2 trial of the ECOG-ACRIN Cancer Research Group (EA8153).
Org: University of Wisconsin Carbone Cancer Center, Madison, WI, Dana-Farber Cancer Institute, Boston, MA, University of Wisconsin,
Abstract
Comparison of immunoglobulin high-throughput sequencing MRD in bone marrow and peripheral blood in pediatric B-ALL: A report from the Children's Oncology Group AALL1731.
Org: Adaptive Biotechnologies, Baylor College of Medicine, Servier Pharmaceuticals, Perlmutter Cancer Center, New York University Langone Health, University of Washington School of Medicine,
Abstract
Long-term follow up of E3311, a phase II trial of transoral surgery (TOS) followed by pathology-based adjuvant treatment in HPV-associated (HPV+) oropharynx cancer (OPC): A trial of the ECOG-ACRIN Cancer Research Group.
Org: Yale University School of Medicine and Yale Cancer Center, Dana Farber Cancer Institute – ECOG-ACRIN Biostatistics Center, Johns Hopkins University, University of Pennsylvania Medical Center, University of Maryland Marlene and Stewart Greenebaum Cancer Center,
Abstract
The potential role of serial circulating tumor DNA (ctDNA) testing after upfront surgery to guide adjuvant chemotherapy for early stage pancreatic cancer: The AGITG DYNAMIC-Pancreas trial.
Org: Northern Health, Peter MacCallum Cancer Centre, Melbourne, Australia, Walter and Eliza Hall Institute of Medical Research, University of Melbourne, Melbourne, VIC, Australia,
Abstract
Cost-effectiveness of a circulating tumor fraction molecular biomarker for treatment response monitoring.
Org: Tempus AI, Perelman School of Medicine at the University of Pennsylvania, Abramson Cancer Center, Ochsner Health Center, Johns Hopkins University,
Abstract
Ambulatory teclistamab administration in patients with relapsed/refractory multiple myeloma.
Org: Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University,
Clinical trial
Safety for Home Administration of Microdose Psilocybin Use
Status: Not yet recruiting, Estimated PCD: 2026-06-01
Clinical trial
Pioglitazone for the Treatment of Idiopathic Gastroparesis (PIOGAS Study)
Status: Active (not recruiting), Estimated PCD: 2025-09-29
Clinical trial
Evaluating a Mechanistically-Supported Pharmacotherapy to Treat Opioid Withdrawal
Status: Recruiting, Estimated PCD: 2027-01-31
Clinical trial
Escitalopram and Language Intervention for Subacute Aphasia (ELISA)
Status: Recruiting, Estimated PCD: 2025-09-18
Clinical trial
Psilocybin-facilitated Smoking Cessation Treatment: A Pilot Study
Status: Completed, Estimated PCD: 2023-05-01
Clinical trial
Effects of Sleep Disruption on Drug Response
Status: Recruiting, Estimated PCD: 2025-04-29
Clinical trial
Low-Dose Ketamine Infusion for the Treatment of Multiple Sclerosis Fatigue (INKLING-MS)
Status: Recruiting, Estimated PCD: 2025-12-01
Clinical trial
Autologous Volar Fibroblast Injection Into the Stump Site of Amputees
Status: Recruiting, Estimated PCD: 2028-04-01
Clinical trial
Renal Anhydramnios Fetal Therapy (RAFT) Trial
Status: Recruiting, Estimated PCD: 2025-04-01
Clinical trial
Behavioral Pharmacology of THC and Beta-Myrcene
Status: Not yet recruiting, Estimated PCD: 2025-11-01
Clinical trial
Effects of Lactoferrin on Chronic Inflammation in the Elderly
Status: Completed, Estimated PCD: 2019-02-25
Clinical trial
Targeting Cerebrovascular Reactivity for Precision Medicine: Pilot Trial of Atorvastatin
Status: Recruiting, Estimated PCD: 2024-07-31
Clinical trial
Influenza Immunization in Adults Over Age 75
Status: Recruiting, Estimated PCD: 2025-03-01
Clinical trial
Psilocybin and Affective Function in Chronic Lower Back Pain Depression
Status: Recruiting, Estimated PCD: 2026-07-30
Clinical trial
A Randomized Controlled Trial to Study Reduced Opioid Prescription After Laparoscopic Hysterectomy
Status: Active (not recruiting), Estimated PCD: 2024-12-31
Clinical trial
The Impact of Product Formulation on the Pharmacokinetics and Pharmacodynamics of Cannabis Edibles
Status: Not yet recruiting, Estimated PCD: 2026-01-01
Clinical trial
Assessing a Clinically-meaningful Opioid Withdrawal Phenotype
Status: Recruiting, Estimated PCD: 2025-11-30
Clinical trial
Preclinical Studies of Omalizumab in Chronic Rhinosinusitis With Nasal Polyposis
Status: Recruiting, Estimated PCD: 2024-05-30
Clinical trial
Evaluating Cannabidiol (CBD) to Enhance the Analgesic Effect of Hydromorphone in Humans
Status: Completed, Estimated PCD: 2022-11-01
Clinical trial
Proof of Concept Investigation of the Steroid-reducing Effects of Crisaborole in Children
Status: Active (not recruiting), Estimated PCD: 2024-12-01
Clinical trial
The Cancer of the Pancreas Screening-5 CAPS5)Study
Status: Recruiting, Estimated PCD: 2024-10-01
Clinical trial
A Sequenced Strategy for Improving Outcomes in People With Knee Osteoarthritis Pain
Status: Recruiting, Estimated PCD: 2024-11-01
Clinical trial
Roflumilast or Azithromycin to Prevent COPD Exacerbations (RELIANCE)
Status: Recruiting, Estimated PCD: 2026-03-01
Clinical trial
Scrambler Therapy for Post-Stroke Pain
Status: Recruiting, Estimated PCD: 2025-12-01
Clinical trial
Effects of Glucocorticoids on Cognition in HIV-infected Women
Status: Completed, Estimated PCD: 2023-09-08
Clinical trial
Shortened Regimen for Drug-susceptible TB in Children
Status: Not yet recruiting, Estimated PCD: 2027-09-30
Clinical trial
The Impact of Vaporized Cannabis Administration and Co-Administration of Alcohol on Impairment
Status: Not yet recruiting, Estimated PCD: 2027-08-01
Clinical trial
Evolocumab in Acute Coronary Syndrome: A Double-Blind Randomized Placebo Controlled Study
Status: Active (not recruiting), Estimated PCD: 2024-10-25
Clinical trial
5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder
Status: Recruiting, Estimated PCD: 2025-05-01
Clinical trial
Metformin IN Asthma for Overweight and Obese Individuals (MINA)
Status: Not yet recruiting, Estimated PCD: 2026-09-30
Clinical trial
Pilot Study to Evaluate Docosahexaenoic Acid as Treatment for Residual Amblyopia
Status: Withdrawn, Estimated PCD: 2024-07-01
Clinical trial
Reduced Nicotine Cigarette Purchasing Decisions
Status: Completed, Estimated PCD: 2023-03-29
Clinical trial
Eculizumab in HELLP Syndrome
Status: Completed, Estimated PCD: 2023-08-31
Clinical trial
The Impact of COVID-19 on Maternal and Neonatal Outcomes
Status: Recruiting, Estimated PCD: 2025-05-05
Clinical trial
DREAM-01: Optimization of a Tenofovir Enema for HIV Prevention
Status: Completed, Estimated PCD: 2019-05-01
Clinical trial
Oral Cannabidiol for Tobacco Cessation
Status: Recruiting, Estimated PCD: 2024-11-01
Clinical trial
Decitabine for COVID-19 Pneumonia-ARDS Treatment: DART Trial
Status: Active (not recruiting), Estimated PCD: 2024-09-01
Clinical trial
Multimodal Brain Imaging of the Neural Effects of Methylphenidate in Patients With ADHD
Status: Recruiting, Estimated PCD: 2025-05-01
Clinical trial
Safety and Tolerability of Psilocybin in Post-Traumatic Stress Disorder
Status: Withdrawn, Estimated PCD: 2025-12-01
Clinical trial
Kids MoD PAH Trial: Mono- vs. Duo-Therapy for Pediatric Pulmonary Arterial Hypertension
Status: Recruiting, Estimated PCD: 2026-09-30
Clinical trial
Phase II Study of Baked Milk Oral Immunotherapy for the Treatment of Cow's Milk Allergy
Status: Completed, Estimated PCD: 2021-01-25
Clinical trial
Estrogen Supplementation and Bone Health in Women With CF (STURDY)
Status: Recruiting, Estimated PCD: 2025-12-01
Clinical trial
Peripheral Modulation of Muscle Stiffness and Spasticity
Status: Recruiting, Estimated PCD: 2024-11-16
Clinical trial
The Role of IL5 in Epithelial Cell Integrity
Status: Recruiting, Estimated PCD: 2025-01-01
Clinical trial
Phase 1 Biodistribution and Pathophysiology Study of 18F-Fluorodeoxysorbitol (18F-FDS)
Status: Recruiting, Estimated PCD: 2025-05-31
Clinical trial
The Effect of Delta-8-THC vs Delta-9-THC on Simulated Driving Performance and Measures of Impairment
Status: Not yet recruiting, Estimated PCD: 2025-12-01
Clinical trial
Effects of Commonly Used Medications on Mood and Choice
Status: Completed, Estimated PCD: 2024-02-01
Clinical trial
The Role of Bimatoprost in Graves' Periorbitopathy
Status: Recruiting, Estimated PCD: 2024-07-01
Clinical trial
Effects of Psilocybin on Electrophysiology and the Dynamic Content of Thought
Status: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Behavioral Pharmacology of THC and D-limonene
Status: Completed, Estimated PCD: 2022-06-28
Clinical trial
Human Craniomaxillofacial Allotransplantation
Status: Recruiting, Estimated PCD: 2026-08-01
Clinical trial
Sodium Citrate 4% Locking Solution for Children Requiring Home Parenteral Nutrition
Status: Completed, Estimated PCD: 2023-11-28
Clinical trial
Behavioral Pharmacology of Orally Administered THC and D-limonene
Status: Not yet recruiting, Estimated PCD: 2027-07-01
Clinical trial
Propranolol for Sleep Apnea Therapy
Status: Completed, Estimated PCD: 2024-05-01
Clinical trial
Vericiguat in Patients With Metabolic Syndrome and Coronary Vascular Dysfunction
Status: Recruiting, Estimated PCD: 2025-06-16
Clinical trial
Measuring Acute Drug Demand in Humans
Status: Recruiting, Estimated PCD: 2027-10-31
Clinical trial
Randomized Trial to Determine Effective Aspirin Dose in COPD
Status: Recruiting, Estimated PCD: 2026-12-01
Clinical trial
Dupilumab De-escalation in Pediatric Atopic Dermatitis: A Pilot Trial
Status: Recruiting, Estimated PCD: 2026-04-01
Clinical trial
Dinner Time for Obesity and Prediabetes
Status: Recruiting, Estimated PCD: 2027-06-30
Clinical trial
Analysis of the Microbiome in Rosacea
Status: Recruiting, Estimated PCD: 2025-09-01
Clinical trial
Evaluating the Effects of Ocrelizumab on B-cell Tolerance Defect in Relapsing Multiple Sclerosis
Status: Active (not recruiting), Estimated PCD: 2024-12-31
Clinical trial
Sildenafil for Early Pulmonary Vascular Disease in Scleroderma
Status: Recruiting, Estimated PCD: 2024-09-01
Clinical trial
A Randomized Control Trial for Opioid Use After Laparoscopic Salpingectomy
Status: Recruiting, Estimated PCD: 2025-05-01
Clinical trial
Smoking Cessation Pilot Program on 9 South
Status: Withdrawn, Estimated PCD: 2023-04-01
Clinical trial
Biomarker and Edema Attenuation in IntraCerebral Hemorrhage (BEACH) Phase 2a Trial
Status: Recruiting, Estimated PCD: 2025-12-25
Clinical trial
High Relaxivity Contrast Agent for Cardiac MR in the Myocardial Scar Assessment
Status: Not yet recruiting, Estimated PCD: 2025-12-01
Clinical trial
Statin Adjunctive Therapy for TB (StAT- TB)
Status: Completed, Estimated PCD: 2022-08-31
Clinical trial
Improving Cardiovascular Health Risks in Adults With Epilepsy on a Modified Atkins Diet
Status: Not yet recruiting, Estimated PCD: 2027-01-01
Clinical trial
Comparative Pharmacokinetic and Pharmacodynamic Effects of Delta-8 and Delta-9 THC
Status: Recruiting, Estimated PCD: 2025-06-01
Clinical trial
Interactions Between Cannabinoids and Cytochrome P450-Metabolized Drugs
Status: Completed, Estimated PCD: 2022-03-16
Clinical trial
Cognitive Effects of Nimodipine in Patients With Schizophrenia
Status: Completed, Estimated PCD: 2023-05-12
Clinical trial
Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder
Status: Recruiting, Estimated PCD: 2025-08-31
Clinical trial
Effects of Psilocybin in Post-Treatment Lyme Disease
Status: , Estimated PCD: 2024-09-30
Clinical trial
Brain Imaging of Nicotinic Acetylcholine Receptors in Tobacco Users and Nonusers
Status: Completed, Estimated PCD: 2022-10-30
Clinical trial
Glycemia in Diabetic Elders Trial
Status: Terminated, Estimated PCD: 2017-02-01
Clinical trial
Psilocybin for PTSD With or Without Psychotherapy: A Pilot Study of Safety and Efficacy
Status: Recruiting, Estimated PCD: 2026-05-01
Clinical trial
Intranasal Insulin for Improving Cognitive Function in Multiple Sclerosis
Status: Completed, Estimated PCD: 2021-12-17
Clinical trial
Human Penile Allotransplantation
Status: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
Effects of Psilocybin in Anorexia Nervosa
Status: Completed, Estimated PCD: 2022-01-05
Clinical trial
Using Dronabinol to Enhance the Analgesic Effect of Hydromorphone in Humans
Status: Completed, Estimated PCD: 2020-03-23
Clinical trial
The Pharmacokinetics and Pharmacodynamics of Hemp-based Topical Cannabinoid Products
Status: Completed, Estimated PCD: 2022-09-16
Clinical trial
Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial
Status: Recruiting, Estimated PCD: 2027-05-31
Clinical trial
Differences in Cannabis Impairment and Its Measurement Due to Route of Administration
Status: Completed, Estimated PCD: 2019-06-11
Clinical trial
Brain Imaging of Cannabinoid Receptors in Women
Status: Completed, Estimated PCD: 2020-03-31
Clinical trial
Effects of Dietary Conditions on Drug Response
Status: Terminated, Estimated PCD: 2023-02-02
Clinical trial
Behavioral Pharmacology of THC and Alpha-pinene
Status: Completed, Estimated PCD: 2024-03-08
Clinical trial
Effects of Psilocybin in Obsessive Compulsive Disorder
Status: Recruiting, Estimated PCD: 2025-09-12
Clinical trial
Human Upper Extremity Allotransplantation
Status: Recruiting, Estimated PCD: 2036-06-01
Clinical trial
Behavioral Pharmacology of Cannabis and Nicotine
Status: Completed, Estimated PCD: 2023-07-24
Clinical trial
Pilot Trial of Dronabinol Adjunctive Treatment of Agitation in Alzheimer's Disease
Status: Completed, Estimated PCD: 2024-05-31